共 21 条
[1]
Buxton M.J., Health economics in the 1990's, Health Economics of Depression (1st Ed.), pp. 1-13, (1993)
[2]
Blumenschein K., Johannesson M., Economic evaluation in healthcare, Pharmacoeconomics, 10, 2, pp. 114-122, (1996)
[3]
Buxton M.J., Et al., Modelling in economic evaluation: An unavoidable fact of life, Health Economics, 6, 3, pp. 217-227, (1997)
[4]
Bloom B., Buxton M., Drummond M., Luce B., Sheldon T., The pros and cons of modelling in economic evaluation, OHE Briefing, 33, pp. 1-12, (1997)
[5]
Fletcher J., Hicks N.R., Kay J.D.S., Boyd P.A., Using decision analysis to compare policies for antenatal screening for Down's syndrome, British Medical Journal, 311, pp. 351-357, (1995)
[6]
Lieu T.A., Watson S.E., Washington A.E., The cost-effectiveness of prenatal carrier screening for cystic fibrosis, Obstetrics and Gynaecology, 84, 6, pp. 903-912, (1994)
[7]
Revicki D.A., Et al., Modelling the cost effectiveness of antidepressant treatment in primary care, Pharmacoeconomics, 8, 6, pp. 524-540, (1995)
[8]
Briggs A.H., Sculpher M.J., Logan R.P., Aldous J., Ramsay M.E., Baron J.H., Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age, British Medical Journal, 312, 7042, pp. 1321-1325, (1996)
[9]
Davies A., Cuninghame K., Breast Cancer: Screening and Treatment, (1992)
[10]
Fox K.R., Adjuvant therapies for node-positive operable breast cancer, Breast Cancer Treatment - A Comprehensive Guide to Management (1st Ed.), pp. 265-289, (1991)